PriceTargets.com logo

NASDAQ:PRSC - The Providence Service Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $152.00
  • Forecasted Upside: 19.05 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$127.68 As of 03/3/2021 01:00 AM ET
▼ -5.91 (-4.42%)
1 month | 3 months | 12 months
Get New The Providence Service Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PRSC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRSC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$152.00
▲ +19.05% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for The Providence Service in the last 3 months. The average price target is $152.00, with a high forecast of $152.00 and a low forecast of $152.00. The average price target represents a 19.05% upside from the last price of $127.68.
Buy
The current consensus among 3 polled investment analysts is to buy stock in The Providence Service.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/8/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/6/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/4/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/3/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/3/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/11/2020Jefferies Financial GroupInitiated CoverageBuyLow
i
11/9/2020Barrington ResearchBoost Price TargetOutperform$104.00 ➝ $152.00High
i
Rating by Michael Petusky at Barrington Research
9/15/2020Barrington ResearchInitiated CoverageBuy$104.00Medium
i
Rating by Michael Petusky at Barrington Research
8/7/2020Barrington ResearchBoost Price TargetOutperform$87.00 ➝ $104.00High
i
Rating by Michael Petusky at Barrington Research
7/16/2020Lake Street CapitalInitiated CoverageBuyLow
i
6/9/2020Barrington ResearchInitiated CoverageBuy$87.00Low
i
Rating by Michael Petusky at Barrington Research
5/26/2020Barrington ResearchInitiated CoverageOutperform$84.00Medium
i
Rating by M. Petusky at Barrington Research
11/9/2017Barrington ResearchReiterated RatingOutperform$67.00N/A
i
8/10/2017Barrington ResearchBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $60.00Low
i
1/31/2017Avondale PartnersDowngradeOutperform ➝ Market PerformN/A
i
Rating by S. Svenpladsen at Avondale Partners
11/10/2016Avondale PartnersDowngradeOutperform ➝ Market PerformN/A
i
Rating by S. Svenpladsen at Avondale Partners
11/2/2016Avondale PartnersUpgradeMarket Perform ➝ OutperformN/A
i
Rating by S. Svenpladsen at Avondale Partners
10/11/2016Avondale PartnersInitiated CoverageMarket PerformN/A
i
3/14/2016Barrington ResearchBoost Price TargetOutperform$63.00 ➝ $64.00N/A
i
Rating by Michael Petusky at Barrington Research
(Data available from 3/3/2016 forward)
The Providence Service logo
The Providence Service Corporation provides healthcare services in the United States. It operates through Non-Emergency Medical Transportation Services (NET Services) and Matrix Investment segments. The NET Services segment offers non-emergency medical transportation services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. The Matrix Investment segment provides in-home care optimization services, including comprehensive health assessments through a network of community-based clinicians and a fleet of mobile health clinics. The company was founded in 1996 and is headquartered in Atlanta, Georgia.
Read More

Today's Range

Now: $127.68
$127.27
$135.08

50 Day Range

MA: $161.47
$126.64
$182.25

52 Week Range

Now: $127.68
$40.40
$156.30

Volume

114,345 shs

Average Volume

128,367 shs

Market Capitalization

$1.81 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Frequently Asked Questions

What sell-side analysts currently cover shares of The Providence Service?

The following Wall Street analysts have issued stock ratings on The Providence Service in the last year: Barrington Research, Jefferies Financial Group Inc., Lake Street Capital, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for PRSC.

What is the current price target for The Providence Service?

1 Wall Street analysts have set twelve-month price targets for The Providence Service in the last year. Their average twelve-month price target is $152.00, suggesting a possible upside of 19.0%. Barrington Research has the highest price target set, predicting PRSC will reach $152.00 in the next twelve months. Barrington Research has the lowest price target set, forecasting a price of $152.00 for The Providence Service in the next year.
View the latest price targets for PRSC.

What is the current consensus analyst rating for The Providence Service?

The Providence Service currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRSC will outperform the market and that investors should add to their positions of The Providence Service.
View the latest ratings for PRSC.

What other companies compete with The Providence Service?

Other companies that are similar to The Providence Service include Laboratory Co. of America, Quest Diagnostics, DaVita, Amedisys, R1 RCM, Chemed, LHC Group, AMN Healthcare Services, MEDNAX, CorVel, Tivity Health, Cross Country Healthcare and Interpace Biosciences.

How do I contact The Providence Service's investor relations team?

The Providence Service's physical mailing address is 1275 Peachtree Street Sixth Floor, Atlanta GA, 30309. The company's listed phone number is 404-888-5800 and its investor relations email address is [email protected] The official website for The Providence Service is www.prscholdings.com.